Abstract:Background: Cardiogenic shock (CS) is a critical illness with a high mortality rate in clinical practice. Although some biomarkers have been found to be associated with mortality in patients suffering from CS in previous studies. The albumin-corrected anion gap (ACAG) has not been studied in depth. Our study aimed to explore the relationship between ACAG and mortality in patients with CS. Methods: All baseline data was extracted from Medical Information Mart for Intensive Care-IV version: 2.0 (MIMIC-IV). According to the prognosis at 30 days of follow-up, they were divided into survivors and non-survivors groups. The survival curves between the two groups were drawn using the Kaplan-Meier method and the log-rank test. Valid factors were selected using the least absolute shrinkage and selection operator (LASSO) logistic analysis model. Analysis was performed to investigate the relationship between mortality and all enrolled patients using restricted cubic spline (RCS) and Cox proportional hazards models. Receiver operating characteristic (ROC) curves were used to assess the predictive ability of ACAG. Evaluation of final result stability using sensitivity analysis. Results: 839 cases were selected to meet the inclusion criteria and categorized into survivors and non-survivors groups in the final analysis. The ACAG value measured for the first time at the time of admission was selected as the research object. Kaplan-Meier (K-M) survival curves showed that cumulative 30- and 90-day survival decreased progressively with elevated ACAG (p < 0.001), and multifactorial Cox regression analyses showed ACAG to be an independent risk factor for increased 30- and 90-day mortality in patients suffering from CS (p < 0.05). RCS curves revealed that all-cause mortality in this group of patients increased with increasing ACAG ( χ 2 = 5.830, p = 0.120). The ROC curve showed that the best cutoff value for ACAG for predicting 30-day mortality in patients with CS was 22.625, with a sensitivity of 44.0% and a specificity of 74.7%. The relationship between ACAG and CS short-term mortality remained stable in all sensitivity analyses (All p < 0.05). Conclusions: The ACAG is an independent risk factor for 30- and 90-day mortality in CS patients and predicts poor clinical outcomes in CS patients. According to our study, elevated ACAG at admission, especially when ACAG > 20 mmol/L, was an independent predictor of all-cause mortality in CS.

Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.

Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury

C-reactive Protein/Albumin Ratio As a Prognostic Indicator in Posttraumatic Shock and Outcome of Multiple Trauma Patients

Preoperative C-reactive Protein/albumin Ratio to Predict Mortality and Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

The Clinical Value of Serum Creatinine-to-Bilirubin Ratio in Predicting the Severity and Prognosis of Acute Pancreatitis

Association between serum albumin creatinine ratio and all-cause mortality in intensive care unit patients with heart failure

The Impact of C-Reactive Protein-To-Albumin Ratio on Mortality in Patients with Acute Kidney Injury Requiring Continuous Renal Replacement Therapy: A Multicenter Retrospective Study

C-reactive Protein-to-serum Albumin Ratio As a Novel Predictor of Long-Term Outcomes in Coronary Artery Disease Patients Who Have Undergone Percutaneous Coronary Intervention: Analysis of a Real-World Retrospective Cohort Study

Prognostic Value of Preoperative High-Sensitivity C-reactive Protein to Albumin Ratio in Patients with Dilated Cardiomyopathy Receiving Pacemaker Therapy: A Retrospective Two-Center Study in China

Association between the C-reactive protein to albumin ratio and poor clinical outcome in patients with spontaneous intracerebral hemorrhage

Microalbuminuria Can Predict the Development of Acute Kidney Injury in Critically Ill Septic Patients

The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: a national cohort study

Association between albumin corrected anion gap and all-cause mortality in critically ill patients with acute kidney injury: a retrospective study based on MIMIC-IV database

Association of serum albumin-to-creatinine ratio with in-hospital mortality in patients with severe acute pancreatitis: a retrospective study

Prognostic value of serum albumin-to-creatinine ratio in patients with acute myocardial infarction: Results from the retrospective evaluation of acute chest pain study

Elevated CK-MB levels are associated with adverse clinical outcomes in acute pancreatitis: a propensity score-matched study

Preoperative C-reactive protein/albumin ratio and mortality of off-pump coronary artery bypass graft

Predictive value of C-reactive protein-to-albumin ratio for risk of 28-day mortality in patients with severe pneumonia

Association between alkaline phosphatase to albumin ratio and mortality among patients with sepsis

Association between serum creatinine and 30 days all-cause mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: analysis of the MIMIC-IV database

Association between Albumin-Corrected Anion Gap and Mortality in Patients with Cardiogenic Shock